Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 21

1.

Usefulness of Medical Thoracoscopy in the Management of Pleural Effusion Caused by Chronic Renal Failure.

Colella S, Fioretti F, Massaccesi C, Primomo GL, Panella G, D'Emilio V, Pela R.

J Bronchology Interv Pulmonol. 2017 Oct;24(4):285-289. doi: 10.1097/LBR.0000000000000421.

PMID:
28957888
2.

An unusual thoracic localizations of Erdheim- Chester disease: A case report.

Massaccesi C, Colella S, Fioretti F, D'Emilio V, Panella G, Primomo G, Barbisan F, Pela R, Poletti V.

Respir Med Case Rep. 2017 Jan 16;20:116-119. doi: 10.1016/j.rmcr.2017.01.006. eCollection 2017.

3.

Comparing LDA-1/2, HSE03, HSE06 and G₀W₀ approaches for band gap calculations of alloys.

Pela RR, Marques M, Teles LK.

J Phys Condens Matter. 2015 Dec 23;27(50):505502. doi: 10.1088/0953-8984/27/50/505502. Epub 2015 Nov 26.

PMID:
26609566
4.

Clinical efficacy and tolerability of an immune-stimulant(*) constituted by inactivated bacterial bodies in the prophylaxis of infectious episodes of airways: a double blind, placebo-controlled, randomized, multicentre study.

Carlone S, Minenna M, Morlino P, Mosca L, Pasqua F, Pela R, Schino P, Tubaldi A, Tupputi E, De Benedetto F; Buccalin Trial Group.

Multidiscip Respir Med. 2014 Nov 19;9(1):58. doi: 10.1186/2049-6958-9-58. eCollection 2014.

5.

COPD: maximization of bronchodilation.

Nardini S, Camiciottoli G, Locicero S, Maselli R, Pasqua F, Passalacqua G, Pela R, Pesci A, Sebastiani A, Vatrella A.

Multidiscip Respir Med. 2014 Oct 15;9(1):50. doi: 10.1186/2049-6958-9-50. eCollection 2014. Review.

6.

Tiotropium Respimat inhaler and the risk of death in COPD.

Wise RA, Anzueto A, Cotton D, Dahl R, Devins T, Disse B, Dusser D, Joseph E, Kattenbeck S, Koenen-Bergmann M, Pledger G, Calverley P; TIOSPIR Investigators.

N Engl J Med. 2013 Oct 17;369(16):1491-501. doi: 10.1056/NEJMoa1303342. Epub 2013 Aug 30.

7.

Medical treatment choices for patients affected by advanced NSCLC in routine clinical practice: results from the Italian observational "SUN" (Survey on the lUng cancer maNagement) study.

Gridelli C, Ardizzoni A, Barni S, Crinò L, Caprioli A, Piazza E, Lorusso V, Barbera S, Zilembo N, Gebbia V, Adamo V, Pela R, Marangolo M, Morena R, Filippelli G, Buscarino C, Alabiso O, Maione P, Venturino P, De Marinis F.

Lung Cancer. 2011 Dec;74(3):462-8. doi: 10.1016/j.lungcan.2011.04.011. Epub 2011 May 17.

PMID:
21592612
8.

Patient, doctor, disease, and informed consent.

Pela R.

Multidiscip Respir Med. 2011 Feb 28;6(1):8-9. doi: 10.1186/2049-6958-6-1-8. No abstract available.

9.

Explaining cyclodextrin-mycotoxin interactions using a 'natural' force field.

Amadasi A, Dall'asta C, Ingletto G, Pela R, Marchelli R, Cozzini P.

Bioorg Med Chem. 2007 Jul 1;15(13):4585-94. Epub 2007 Apr 10.

PMID:
17449255
10.

Long-term oral n-acetylcysteine reduces exhaled hydrogen peroxide in stable COPD.

De Benedetto F, Aceto A, Dragani B, Spacone A, Formisano S, Pela R, Donner CF, Sanguinetti CM.

Pulm Pharmacol Ther. 2005;18(1):41-7. Epub 2004 Dec 8.

PMID:
15607126
11.

An observational study on the epidemiology of respiratory tract bacterial pathogens and their susceptibility to four injectable beta-lactam antibiotics: piperacillin, piperacillin/tazobactam, ceftazidime and ceftriaxone.

Varotto F, Maria GD, Azzaro R, Bellissima P, Amato R, Fogliani V, Muscianisi G, Vitale S, Girbino G, Andò F, Laganà P, Delia S, Jacoviello C, Maierna G, Pezza A, Covelli I, Magrì M, Napoletano G, Rossi A, Marone P, Sanguinetti C, Pela R, Tedeschi D, Viola B, Cicciarella S, Messina G, Rizza S, Fraschini F.

J Chemother. 2001 Aug;13(4):413-23. Erratum in: J Chemother 2001 Dec;13(6):666. Sabato V [corrected to Vitale S].

PMID:
11589485
12.

N-acetylcysteine reduces the exacerbation rate in patients with moderate to severe COPD.

Pela R, Calcagni AM, Subiaco S, Isidori P, Tubaldi A, Sanguinetti CM.

Respiration. 1999 Nov-Dec;66(6):495-500.

PMID:
10575333
13.

Causes of chronic persistent cough in adult patients: the results of a systematic management protocol.

Marchesani F, Cecarini L, Pela R, Sanguinetti CM.

Monaldi Arch Chest Dis. 1998 Oct;53(5):510-4.

PMID:
9861809
14.

A 6-month comparison between formoterol and salmeterol in patients with reversible obstructive airways disease.

Vervloet D, Ekström T, Pela R, Duce Gracia F, Kopp C, Silvert BD, Quebe-Fehling E, Della Cioppa G, Di Benedetto G.

Respir Med. 1998 Jun;92(6):836-42.

PMID:
9850367
15.

Airways microbial flora in COPD patients in stable clinical conditions and during exacerbations: a bronchoscopic investigation.

Pela R, Marchesani F, Agostinelli C, Staccioli D, Cecarini L, Bassotti C, Sanguinetti CM.

Monaldi Arch Chest Dis. 1998 Jun;53(3):262-7.

PMID:
9785808
16.

Pulmonary arteriovenous fistula in a patient with Rendu-Osler-Weber syndrome.

Marchesani F, Cecarini L, Pela R, Catalini G, Sabbatini A, Fianchini A, Sanguinetti CM.

Respiration. 1997;64(5):367-70.

PMID:
9311054
17.

Localized fibrous pleural tumour of the interlobular pleura.

Sanguinetti CM, Marchesani F, Ranaldi R, Pela R, Cecarini L.

Eur Respir J. 1996 May;9(5):1094-6.

18.

Bronchoalveolar lavage fluid level of carcinoembryonic antigen in the diagnosis of peripheral lung cancer.

Sanguinetti CM, Riccioni G, Marchesani F, Pela R, Cecarini L.

Monaldi Arch Chest Dis. 1995 May;50(3):177-82.

PMID:
7663486
19.

Neurogenic diabetes insipidus: an unusual clinical presentation of small cell lung cancer.

Sanguinetti CM, Marchesani F, Bichi-Secchi E, Staccioli D, Pela R, Cecarini L.

Monaldi Arch Chest Dis. 1993;48(2):130-3.

PMID:
8390898
20.

Tracheobronchopathia osteochondroplastica.

Marchesani F, Staccioli D, Pela R, Ranaldi R, Cecarini L, Sanguinetti CM.

Monaldi Arch Chest Dis. 1993;48(3):210-2.

PMID:
8369785

Supplemental Content

Loading ...
Support Center